Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease

Saved in:
Bibliographic Details
Published inAnnals of internal medicine Vol. 175; no. 1; p. W3
Main Author Qiu, Mei
Format Journal Article
LanguageEnglish
Published United States 01.01.2022
Subjects
Cardiovascular Diseases - chemically induced
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - prevention & control
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Glucagon-Like Peptide-1 Receptor
Glucose
Humans
Hypoglycemic Agents - adverse effects
Sodium
Sodium-Glucose Transporter 2 Inhibitors - adverse effects
Online AccessGet more information

Cover

Author Qiu, Mei
Author_xml – sequence: 1
  givenname: Mei
  orcidid: 0000-0001-5013-657X
  surname: Qiu
  fullname: Qiu, Mei
  organization: Department of General Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35038402$$D View this record in MEDLINE/PubMed
BookMark eNpdkM1KAzEUhYMoWqvgE0heIJpkZjozy9L6B4VK_VtKJrmxsW1ScjOCL-rzmKJuXN3DOR_f4h6TfR88EHIm-EVdyNHlTArGaz7aIwNRFS0ral4ekWPEd8550cjmkBwVVU4llwPy9RCM6zfsZt3rgEAnIUXlcRtigsgkvfNL17kUItJniNgj3ZHqLXi2diug97BNzgATdAE65xDpOI8OE1LlDU1LoAuHK2rzMlHRuPChUPdrFem8TzpsAKnzdBH65DzskCxVyYHPhheXlnTqVAcpY2MdA2JGEryF6HIT7H_n1CEohBNyYNUa4fT3DsnT9dXj5JbN5jd3k_GMaVGXiRWKQ9FyMJUGA1Zaa2wjlSqlbaUA0wndiao1uoSiGVUcNNe8ElVjW14rO5JDcv7j3fbdBszrNrqNip-vfw-W38afgag
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.7326/L21-0706
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1539-3704
ExternalDocumentID 35038402
Genre Letter
Comment
GroupedDBID ---
..I
.55
.GJ
.XZ
08G
1CY
23M
2WC
354
36B
39C
3O-
3V.
4.4
53G
5GY
5RE
5RS
6J9
7RV
7X7
88E
8C1
8F7
8FI
8FJ
8G5
8R4
8R5
AAKAS
AAQOH
AAQQT
AARDX
AAWTL
AAYOK
ABBLC
ABCQX
ABJNI
ABOCM
ABPMR
ABUWG
ACBNA
ACGFO
ACGFS
ADBBV
ADZCM
AEGXH
AENEX
AERZD
AFCHL
AFFNX
AFKRA
AHJKT
AHMBA
AI.
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AQUVI
ASPBG
AVWKF
AZFZN
AZQEC
BCR
BCU
BEC
BENPR
BKEYQ
BKNYI
BLC
BPHCQ
BTJBQ
BVXVI
BZLQD
C1A
C45
CCPQU
CGR
CUY
CVF
DWQXO
E3Z
EBS
ECM
EIF
EJD
EMB
EMOBN
EX3
F5P
FEDTE
FYUFA
G8K
GNUQQ
GUQSH
H13
HMCUK
HVGLF
H~9
IH2
J5H
K-O
K9-
L7B
LPU
M0R
M0T
M1P
M2O
M5~
MV1
MVM
N4W
NAPCQ
NPM
OBH
OCB
OFXIZ
OGEVE
OHH
OHT
OVD
OVIDX
P2P
PCD
PQQKQ
PROAC
PSQYO
Q2X
RWL
RXW
S0X
SJFOW
SJN
SV3
TAE
TEORI
TPH
TR2
TWZ
UKHRP
UKR
VH1
VVN
WH7
WOQ
WOW
X6Y
X7M
XOL
YFH
YOC
YQJ
YYP
ZGI
ZXP
ZY1
~H1
ID FETCH-LOGICAL-c174t-3a0e390ed5cedef2ffdf82aa42f921edb1cb159dc4e38650ec0c05158f907af62
IngestDate Sat Sep 28 08:21:31 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c174t-3a0e390ed5cedef2ffdf82aa42f921edb1cb159dc4e38650ec0c05158f907af62
ORCID 0000-0001-5013-657X
PMID 35038402
ParticipantIDs pubmed_primary_35038402
PublicationCentury 2000
PublicationDate 2022-01-00
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Annals of internal medicine
PublicationTitleAlternate Ann Intern Med
PublicationYear 2022
References 35038405 - Ann Intern Med. 2022 Jan;175(1):W4
34570599 - Ann Intern Med. 2021 Nov;174(11):1528-1541
References_xml
SSID ssj0003828
Score 2.4174733
SourceID pubmed
SourceType Index Database
StartPage W3
SubjectTerms Cardiovascular Diseases - chemically induced
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - prevention & control
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Glucagon-Like Peptide-1 Receptor
Glucose
Humans
Hypoglycemic Agents - adverse effects
Sodium
Sodium-Glucose Transporter 2 Inhibitors - adverse effects
Title Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/35038402
Volume 175
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb5wwEICtTStFuVR9v6s59LZyyxqzLMfVpm1UNekrUXKLbLBb1ASiBC79Rf1F_T2dsYEFkqqPC0KYtdidj_F4dh6MPZexlhGlfSS4OnFprOJqpixfRMZIhfa1du3bdvfmOwfy7VF0NJn86EUt1ZV-kX6_Mq_kf6SK11CulCX7D5LtJsULeI7yxSNKGI9_JePPZZbXp_xNE3a-KquuVPk5F_juf8117trpkFusvpjSnepLWfCT_JuZfqCIlszwGRmPeF6eT5c4iIK_6AIrP1HoOYUiroaBq-_rCr-Ri-aaUlQRGauUy0Q1_3OXNXdIHt7t1rW7dMsxJRxSTkzuS92O5tzu_Vl0qb5z7l2XJ5eiAT7mtfPqmrzvwRCi58EwrdZNUNP5PsSdWvYdVQb8eSV7GF6l--PQdat8J3Dy2FUxqHoInJ06BkKqfiNdjvcfRkdVuNuhDbYRL0iT7pFXqFnxQ9y2-sLG9BAv20fYYpvtx0abFme87N9kN5pdByw9QrfYxBS32eZu80veYT-HJMGIJFiTBJ4kGJAEHUnQkgQtSYAkAZIERBIgSTCUOrQkQV5AQxLdgpM2JAGRBC1J4EmCNUlQ2vGcDUl32cHrV_urHd50_OAp7owrHqrAhElgsig1mbHC2swuhFJS2ETMTKZnqUb7O0uloV61gUmDlJoULWwSxMrOxT12rSgL84BBYlOrRSQSoSMp4kwrYdOZknEaxWGm5w_ZfS-R4zNf1uW4ldWj3448Zltrfp-w6xbfAPMUjdJKP3NE_AJQK5g5
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sodium-Glucose+Cotransporter-2+Inhibitors+Versus+Glucagon-like+Peptide-1+Receptor+Agonists+and+the+Risk+for+Cardiovascular+Outcomes+in+Routine+Care+Patients+With+Diabetes+Across+Categories+of+Cardiovascular+Disease&rft.jtitle=Annals+of+internal+medicine&rft.au=Qiu%2C+Mei&rft.date=2022-01-01&rft.eissn=1539-3704&rft.volume=175&rft.issue=1&rft.spage=W3&rft_id=info:doi/10.7326%2FL21-0706&rft_id=info%3Apmid%2F35038402&rft_id=info%3Apmid%2F35038402&rft.externalDocID=35038402